Edgar Filing: ADVANCED MEDICAL OPTICS INC

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â VA PARTNERS LLC

2. Date of Event Requiring Statement (Month/Day/Year)
06/22/2007

3. Issuer Name and Ticker or Trading Symbol
ADVANCED MEDICAL OPTICS INC [EYE]

(Last)

(First)

(Middle)

435 PACIFIC AVENUE,Â FOURTH FLOOR

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

SAN FRANCISCO,Â CAÂ 94133

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share	5,428,700	I	See Footnote ⁽¹⁾
Common Stock, par value $0.001 per share	627,235	I	See Footnote ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
VA PARTNERS LLC 435 PACIFIC AVENUE FOURTH FLOOR SAN FRANCISCO,Â CAÂ 94133	Â	Â X	Â	Â
VA Partners III, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO,Â CAÂ 94133	Â	Â X	Â	Â
ValueAct Capital Management, L.P. 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO,Â CAÂ 94133	Â	Â X	Â	Â
ValueAct Capital Management, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO,Â CAÂ 94133	Â	Â X	Â	Â
UBBEN JEFFREY W 435 PACIFIC AVENUE, FOURTH FLOOR SAN FRANCISCO,Â CAÂ 94133	Â	Â X	Â	Â
KAMIN PETER H 265 FRANKLIN STREET, 16TH FLOOR BOSTON,Â MAÂ 02110	Â	Â X	Â	Â

Signatures

VA PARTNERS, LLC, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
VALUEACT CAPITAL MASTER FUND, L.P., By: VA PARTNERS, LLC, its General Partner, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
VALUEACT CAPITAL MASTER FUND III, L.P., By: VA PARTNERS III, LLC, its General Partner, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
VA PARTNERS III, LLC, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
VALUEACT CAPITAL MANAGEMENT, L.P., By: VALUEACT CAPITAL MANAGEMENT, LLC, its General Partner, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
VALUEACT CAPITAL MANAGEMENT, LLC, By:/s/ George F. Hamel, Jr., Managing Member		06/26/2007
^**Signature of Reporting Person		Date
/s/ Jeffrey W. Ubben		06/26/2007
^**Signature of Reporting Person		Date
/s/ George F. Hamel, Jr.		06/26/2007
^**Signature of Reporting Person		Date
/s/ Peter H. Kamin		06/26/2007
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reported stock is owned directly by ValueAct Capital Master Fund, L.P and may be deemed to be beneficially owned by (i) VA Partners, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P. and (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P. Jeffrey W. Ubben, Peter H. Kamin and George F. Hamel, Jr. are Managing Members of VA Partners, LLC and ValueAct Capital Management, LLC. The reporting persons disclaim beneficial ownership of the reported stock except to the extent of their pecuniary interest therein.
(2)	The reported stock is owned directly by ValueAct Capital Master Fund III, L.P. and may be deemed to be beneficially owned by (i) VA Partners III, LLC as General Partner of ValueAct Capital Master Fund III, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund III, L.P. and (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P. Jeffrey W. Ubben, Peter H. Kamin and George F. Hamel, Jr. are Managing Members of VA Partners III, LLC and ValueAct Capital Management, LLC. The reporting persons disclaim beneficial ownership of the reported stock except to the extent of their pecuniary interest therein.
Â Remarks: JointÂ FilerÂ Information: Name:Â ValueActÂ CapitalÂ MasterÂ Fund,Â L.P. Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â ValueActÂ CapitalÂ MasterÂ FundÂ III,Â L.P. Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â VAÂ PartnersÂ III,Â LLC Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â ValueActÂ CapitalÂ Management,Â L.P. Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â ValueActÂ CapitalÂ Management,Â LLC Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â JeffreyÂ W.Â Ubben Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â GeorgeÂ F.Â Hamel,Â Jr. Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007 Name:Â PeterÂ H.Â Kamin Address:Â 435Â PacificÂ Avenue,Â 4thÂ Floor,Â SanÂ Francisco,Â CAÂ 94133 DesignatedÂ Filer:Â VAÂ Partners,Â LLC IssuerÂ andÂ Ticker:Â AdvancedÂ MedicalÂ OpticsÂ (EYE) DateÂ ofÂ EventÂ RequiringÂ Statement:Â JuneÂ 22,Â 2007

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.